Diagnostic yield and clinical utility of whole exome sequencing using an automated variant prioritization system, EVIDENCE.
Diagnostic yield and clinical utility of whole exome sequencing using an automated variant prioritization system, EVIDENCE.
复制标题
DOI:
10.1111/cge.13848
复制
发表时间:
2020-12
影响因子:
3.5
通讯作者:
Lee BH
中科院分区:
文献类型:
--
作者:
Seo GH;Kim T;Choi IH;Park JY;Lee J;Kim S;Won DG;Oh A;Lee Y;Choi J;Lee H;Kang HG;Cho HY;Cho MH;Kim YJ;Yoon YH;Eun BL;Desnick RJ;Keum C;Lee BH
EVIDENCE, an automated variant prioritization system, has been developed to facilitate whole exome sequencing analyses. This study investigated the diagnostic yield of EVIDENCE in patients with suspected genetic disorders. DNA from 330 probands (age range, 0‐68 years) with suspected genetic disorders were subjected to whole exome sequencing. Candidate variants were identified by EVIDENCE and confirmed by testing family members and/or clinical reassessments. EVIDENCE reported a total 228 variants in 200 (60.6%) of the 330 probands. The average number of organs involved per patient was 4.5 ± 5.0. After clinical reassessment and/or family member testing, 167 variants were identified in 141 probands (42.7%), including 105 novel variants. These variants were confirmed as being responsible for 121 genetic disorders. A total of 103 (61.7%) of the 167 variants in 95 patients were classified as pathogenic or probably to be pathogenic before, and 161 (96.4%) variants in 137 patients (41.5%) after, clinical assessment and/or family member testing. Factor associated with a variant being regarded as causative includes similar symptom scores of a gene variant to the phenotype of the patient. This new, automated variant interpretation system facilitated the diagnosis of various genetic diseases with a 42.7% diagnostic yield. Schematic diagram showing the number of patients with and without variant identification and family member testing and the proportion of variant classification.
登录
查看更多内容
影响因子:
3.4
作者:
Hoffman-Andrews, Lily
通讯作者:
Hoffman-Andrews, Lily
影响因子:
64.8
作者:
Karczewski, Konrad J;Francioli, Laurent C;MacArthur, Daniel G
通讯作者:
MacArthur, Daniel G
影响因子:
3.5
作者:
Sawyer SL;Hartley T;Dyment DA;Beaulieu CL;Schwartzentruber J;Smith A;Bedford HM;Bernard G;Bernier FP;Brais B;Bulman DE;Warman Chardon J;Chitayat D;Deladoëy J;Fernandez BA;Frosk P;Geraghty MT;Gerull B;Gibson W;Gow RM;Graham GE;Green JS;Heon E;Horvath G;Innes AM;Jabado N;Kim RH;Koenekoop RK;Khan A;Lehmann OJ;Mendoza-Londono R;Michaud JL;Nikkel SM;Penney LS;Polychronakos C;Richer J;Rouleau GA;Samuels ME;Siu VM;Suchowersky O;Tarnopolsky MA;Yoon G;Zahir FR;FORGE Canada Consortium;Care4Rare Canada Consortium;Majewski J;Boycott KM
通讯作者:
Boycott KM
影响因子:
5.3
作者:
Clark, Michelle M.;Starke, Zornitza;Kingsmore, Stephen F.
通讯作者:
Kingsmore, Stephen F.
影响因子:
8.6
作者:
Hinderlich, Stephan;Weidemann, Wenke;Yardeni, Tal;Horstkorte, Ruediger;Huizing, Marjan
通讯作者:
Huizing, Marjan